The Food and Drug Administration approved marketing for four flavored vape products made by Glas Inc. on Tuesday, marking a shift in the agency’s stance on such products as it seeks to balance adult access with youth prevention. The decision comes just days after reports that President Trump had rebuked FDA Commissioner Marty Makary for not moving fast enough on flavored nicotine product approvals.
The agency said the products will be sold with strict age-verification measures, including requiring a government-issued ID and a Bluetooth connection to a smartphone to unlock the device. FDA officials touted this as a technological breakthrough that could reshape how vaping products are regulated.
“By helping to prevent youth use, device access restrictions are a potential game changer,” said Bret Koplow, acting director of the FDA’s Center for Tobacco Products, in a statement.
The approvals mark a notable reversal from the FDA’s previous ban on fruit- and candy-flavored vapes, which the Supreme Court upheld last year. That ban was aimed at curbing a surge in teen vaping, but illicit flavored products have continued to flood the market. A study published last year in the American Journal of Preventive Medicine found that disposable e-cigarettes drove a sharp increase in overall nicotine sales, despite federal restrictions.
The Trump administration’s approach to vaping regulation has been a flashpoint, with some public health advocates warning that easing restrictions could reignite youth addiction. Meanwhile, the president has publicly pushed for more options for adult smokers looking to switch from traditional cigarettes. The Wall Street Journal reported that Trump berated Makary for what he saw as excessive caution, a dynamic that has raised questions about political interference in the FDA’s scientific decisions.
Koplow defended the new policy as a pragmatic step. “This technology is also an indication of the role innovation may serve in the effort to protect young people from threats posed by nicotine use and addiction while helping to enable availability of an expanded array of flavored options for adults who smoke who may use these products to completely switch away from regular cigarettes,” he added.
The four approved products will be marketed exclusively to consumers aged 21 and older, with the FDA requiring companies to use targeted advertising that avoids youth exposure. Critics argue that the measure is insufficient, noting that similar age-verification systems have been easily bypassed in the past. The move also comes as the Trump administration faces a series of other political challenges, including controversial decisions on international security and tariff policy that could reshape trade.
The FDA’s decision is likely to intensify debate in Washington over the proper balance between regulation and innovation, especially as the 2026 midterms approach. Some Republicans have praised the move as a win for adult choice, while Democrats and public health groups have signaled they will push for stricter oversight. The issue also intersects with broader concerns about the administration’s relationship with the scientific community, as other agencies face scrutiny over political pressure.
For now, the FDA is betting that technology can solve a problem that regulation alone could not. Whether that bet pays off will depend on how effectively the new age-verification tools work in practice—and whether the agency can avoid another wave of youth addiction.
